Clinical study of Kampo medicines in chemotherapy-induced oral mucositis for esophageal cancer

Clinical study of Kampo medicines in chemotherapy-induced oral mucositis for esophageal cancer - Clinical study of Kampo medicines in chemotherapy-induced oral mucositis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013183

Enrollment

Registered

2014-04-01

Start date

2014-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral mucotisis

Interventions

Hangeshashinto sherbet in the water 7.5g/day t.i.d. between meals Daiokanzoto sherbet in the water 7.5g/day t.i.d. between meals control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)patient with esophageal cencer in chemotherapy 3)20-year-old or older 4)All patients provided written informed consent before initiation of study-related procedures.

Exclusion criteria

Exclusion criteria: 1)Clinically significant infection 2)Severe organ failures 3)Serious drug allergy 4)Patients who want to be pregnant or pregnant woman 5)Any other medical condition that makes the patient unsuitable for inclusion in the study according to the opinion of the investigator

Design outcomes

Primary

Measure	Time frame
The grade of stomatitis and diarrhea by NCI-CTCAE ver.4.0	—

Countries

Japan

Contacts

Public ContactDaisuke Hinode

The university of Tokushima graduate school institute of health bioscience Department of hygiene and oral health science

hinode@tokushima-u.ac.jp088-633-7543

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026